The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Chicken Marek's Disease Live Vaccine Market Research Report 2025
Synopsis
Marek’s disease (MD) is a chronic infectious disease in chickens caused by alphaherpesvirus. Marek's disease poses a huge threat to the world's poultry industry. Chickens infected with Marek's disease virus (MDV) can develop lymphoma, short-term paralysis, atherosclerosis, permanent nervous system damage, and death; mild infections can also cause laying hens to lay eggs. Production traits such as yield and egg weight decreased significantly.
The global Chicken Marek's Disease Live Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Chicken Marek's Disease Live Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Chicken Marek's Disease Live Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Chicken Marek's Disease Live Vaccine include Harbin Weike Biotechnology, Harbin Guosheng Biotechnology, Fujian Shengwei Biotechnology, Liaoning Yikang Biology, Boehringer Ingelheim Animal Health, MSD Animal Health, Ceva, Zoetis and Dahuanong, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Chicken Marek's Disease Live Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chicken Marek's Disease Live Vaccine.
Report Scope
The Chicken Marek's Disease Live Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Chicken Marek's Disease Live Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Chicken Marek's Disease Live Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Harbin Weike Biotechnology
Harbin Guosheng Biotechnology
Fujian Shengwei Biotechnology
Liaoning Yikang Biology
Boehringer Ingelheim Animal Health
MSD Animal Health
Ceva
Zoetis
Dahuanong
Ruipu Biotechnology
Sinopharm Animal Health
Harbin Pharmaceutical Group Biological Vaccine
Segment by Type
Chicken Marek's Disease Live Vaccine
Chicken Marek's Disease Bivalent Live Vaccine
Segment by Application
Government Tender
Marketing
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Chicken Marek's Disease Live Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Chicken Marek's Disease Live Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Marek’s disease (MD) is a chronic infectious disease in chickens caused by alphaherpesvirus. Marek's disease poses a huge threat to the world's poultry industry. Chickens infected with Marek's disease virus (MDV) can develop lymphoma, short-term paralysis, atherosclerosis, permanent nervous system damage, and death; mild infections can also cause laying hens to lay eggs. Production traits such as yield and egg weight decreased significantly.
The global Chicken Marek's Disease Live Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Chicken Marek's Disease Live Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Chicken Marek's Disease Live Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Chicken Marek's Disease Live Vaccine include Harbin Weike Biotechnology, Harbin Guosheng Biotechnology, Fujian Shengwei Biotechnology, Liaoning Yikang Biology, Boehringer Ingelheim Animal Health, MSD Animal Health, Ceva, Zoetis and Dahuanong, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Chicken Marek's Disease Live Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chicken Marek's Disease Live Vaccine.
Report Scope
The Chicken Marek's Disease Live Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Chicken Marek's Disease Live Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Chicken Marek's Disease Live Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Harbin Weike Biotechnology
Harbin Guosheng Biotechnology
Fujian Shengwei Biotechnology
Liaoning Yikang Biology
Boehringer Ingelheim Animal Health
MSD Animal Health
Ceva
Zoetis
Dahuanong
Ruipu Biotechnology
Sinopharm Animal Health
Harbin Pharmaceutical Group Biological Vaccine
Segment by Type
Chicken Marek's Disease Live Vaccine
Chicken Marek's Disease Bivalent Live Vaccine
Segment by Application
Government Tender
Marketing
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Chicken Marek's Disease Live Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Chicken Marek's Disease Live Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Chicken Marek's Disease Live Vaccine Market Overview
1.1 Product Overview and Scope of Chicken Marek's Disease Live Vaccine
1.2 Chicken Marek's Disease Live Vaccine Segment by Type
1.2.1 Global Chicken Marek's Disease Live Vaccine Market Value Comparison by Type (2024-2030)
1.2.2 Chicken Marek's Disease Live Vaccine
1.2.3 Chicken Marek's Disease Bivalent Live Vaccine
1.3 Chicken Marek's Disease Live Vaccine Segment by Application
1.3.1 Global Chicken Marek's Disease Live Vaccine Market Value by Application: (2024-2030)
1.3.2 Government Tender
1.3.3 Marketing
1.4 Global Chicken Marek's Disease Live Vaccine Market Size Estimates and Forecasts
1.4.1 Global Chicken Marek's Disease Live Vaccine Revenue 2019-2030
1.4.2 Global Chicken Marek's Disease Live Vaccine Sales 2019-2030
1.4.3 Global Chicken Marek's Disease Live Vaccine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Chicken Marek's Disease Live Vaccine Market Competition by Manufacturers
2.1 Global Chicken Marek's Disease Live Vaccine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Chicken Marek's Disease Live Vaccine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Chicken Marek's Disease Live Vaccine Average Price by Manufacturers (2019-2024)
2.4 Global Chicken Marek's Disease Live Vaccine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Chicken Marek's Disease Live Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Chicken Marek's Disease Live Vaccine, Product Type & Application
2.7 Chicken Marek's Disease Live Vaccine Market Competitive Situation and Trends
2.7.1 Chicken Marek's Disease Live Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Chicken Marek's Disease Live Vaccine Players Market Share by Revenue
2.7.3 Global Chicken Marek's Disease Live Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Chicken Marek's Disease Live Vaccine Retrospective Market Scenario by Region
3.1 Global Chicken Marek's Disease Live Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Chicken Marek's Disease Live Vaccine Global Chicken Marek's Disease Live Vaccine Sales by Region: 2019-2030
3.2.1 Global Chicken Marek's Disease Live Vaccine Sales by Region: 2019-2024
3.2.2 Global Chicken Marek's Disease Live Vaccine Sales by Region: 2025-2030
3.3 Global Chicken Marek's Disease Live Vaccine Global Chicken Marek's Disease Live Vaccine Revenue by Region: 2019-2030
3.3.1 Global Chicken Marek's Disease Live Vaccine Revenue by Region: 2019-2024
3.3.2 Global Chicken Marek's Disease Live Vaccine Revenue by Region: 2025-2030
3.4 North America Chicken Marek's Disease Live Vaccine Market Facts & Figures by Country
3.4.1 North America Chicken Marek's Disease Live Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Chicken Marek's Disease Live Vaccine Sales by Country (2019-2030)
3.4.3 North America Chicken Marek's Disease Live Vaccine Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Chicken Marek's Disease Live Vaccine Market Facts & Figures by Country
3.5.1 Europe Chicken Marek's Disease Live Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Chicken Marek's Disease Live Vaccine Sales by Country (2019-2030)
3.5.3 Europe Chicken Marek's Disease Live Vaccine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Netherlands
3.6 Asia Pacific Chicken Marek's Disease Live Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Chicken Marek's Disease Live Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Chicken Marek's Disease Live Vaccine Sales by Country (2019-2030)
3.6.3 Asia Pacific Chicken Marek's Disease Live Vaccine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Southeast Asia
3.6.9 China Taiwan
3.6.10 Australia
3.7 Latin America Chicken Marek's Disease Live Vaccine Market Facts & Figures by Country
3.7.1 Latin America Chicken Marek's Disease Live Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Chicken Marek's Disease Live Vaccine Sales by Country (2019-2030)
3.7.3 Latin America Chicken Marek's Disease Live Vaccine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Chicken Marek's Disease Live Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Chicken Marek's Disease Live Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Chicken Marek's Disease Live Vaccine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Chicken Marek's Disease Live Vaccine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Chicken Marek's Disease Live Vaccine Sales by Type (2019-2030)
4.1.1 Global Chicken Marek's Disease Live Vaccine Sales by Type (2019-2024)
4.1.2 Global Chicken Marek's Disease Live Vaccine Sales by Type (2025-2030)
4.1.3 Global Chicken Marek's Disease Live Vaccine Sales Market Share by Type (2019-2030)
4.2 Global Chicken Marek's Disease Live Vaccine Revenue by Type (2019-2030)
4.2.1 Global Chicken Marek's Disease Live Vaccine Revenue by Type (2019-2024)
4.2.2 Global Chicken Marek's Disease Live Vaccine Revenue by Type (2025-2030)
4.2.3 Global Chicken Marek's Disease Live Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global Chicken Marek's Disease Live Vaccine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Chicken Marek's Disease Live Vaccine Sales by Application (2019-2030)
5.1.1 Global Chicken Marek's Disease Live Vaccine Sales by Application (2019-2024)
5.1.2 Global Chicken Marek's Disease Live Vaccine Sales by Application (2025-2030)
5.1.3 Global Chicken Marek's Disease Live Vaccine Sales Market Share by Application (2019-2030)
5.2 Global Chicken Marek's Disease Live Vaccine Revenue by Application (2019-2030)
5.2.1 Global Chicken Marek's Disease Live Vaccine Revenue by Application (2019-2024)
5.2.2 Global Chicken Marek's Disease Live Vaccine Revenue by Application (2025-2030)
5.2.3 Global Chicken Marek's Disease Live Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global Chicken Marek's Disease Live Vaccine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Harbin Weike Biotechnology
6.1.1 Harbin Weike Biotechnology Corporation Information
6.1.2 Harbin Weike Biotechnology Description and Business Overview
6.1.3 Harbin Weike Biotechnology Chicken Marek's Disease Live Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Harbin Weike Biotechnology Chicken Marek's Disease Live Vaccine Product Portfolio
6.1.5 Harbin Weike Biotechnology Recent Developments/Updates
6.2 Harbin Guosheng Biotechnology
6.2.1 Harbin Guosheng Biotechnology Corporation Information
6.2.2 Harbin Guosheng Biotechnology Description and Business Overview
6.2.3 Harbin Guosheng Biotechnology Chicken Marek's Disease Live Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Harbin Guosheng Biotechnology Chicken Marek's Disease Live Vaccine Product Portfolio
6.2.5 Harbin Guosheng Biotechnology Recent Developments/Updates
6.3 Fujian Shengwei Biotechnology
6.3.1 Fujian Shengwei Biotechnology Corporation Information
6.3.2 Fujian Shengwei Biotechnology Description and Business Overview
6.3.3 Fujian Shengwei Biotechnology Chicken Marek's Disease Live Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Fujian Shengwei Biotechnology Chicken Marek's Disease Live Vaccine Product Portfolio
6.3.5 Fujian Shengwei Biotechnology Recent Developments/Updates
6.4 Liaoning Yikang Biology
6.4.1 Liaoning Yikang Biology Corporation Information
6.4.2 Liaoning Yikang Biology Description and Business Overview
6.4.3 Liaoning Yikang Biology Chicken Marek's Disease Live Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Liaoning Yikang Biology Chicken Marek's Disease Live Vaccine Product Portfolio
6.4.5 Liaoning Yikang Biology Recent Developments/Updates
6.5 Boehringer Ingelheim Animal Health
6.5.1 Boehringer Ingelheim Animal Health Corporation Information
6.5.2 Boehringer Ingelheim Animal Health Description and Business Overview
6.5.3 Boehringer Ingelheim Animal Health Chicken Marek's Disease Live Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Boehringer Ingelheim Animal Health Chicken Marek's Disease Live Vaccine Product Portfolio
6.5.5 Boehringer Ingelheim Animal Health Recent Developments/Updates
6.6 MSD Animal Health
6.6.1 MSD Animal Health Corporation Information
6.6.2 MSD Animal Health Description and Business Overview
6.6.3 MSD Animal Health Chicken Marek's Disease Live Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 MSD Animal Health Chicken Marek's Disease Live Vaccine Product Portfolio
6.6.5 MSD Animal Health Recent Developments/Updates
6.7 Ceva
6.6.1 Ceva Corporation Information
6.6.2 Ceva Description and Business Overview
6.6.3 Ceva Chicken Marek's Disease Live Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Ceva Chicken Marek's Disease Live Vaccine Product Portfolio
6.7.5 Ceva Recent Developments/Updates
6.8 Zoetis
6.8.1 Zoetis Corporation Information
6.8.2 Zoetis Description and Business Overview
6.8.3 Zoetis Chicken Marek's Disease Live Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Zoetis Chicken Marek's Disease Live Vaccine Product Portfolio
6.8.5 Zoetis Recent Developments/Updates
6.9 Dahuanong
6.9.1 Dahuanong Corporation Information
6.9.2 Dahuanong Description and Business Overview
6.9.3 Dahuanong Chicken Marek's Disease Live Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Dahuanong Chicken Marek's Disease Live Vaccine Product Portfolio
6.9.5 Dahuanong Recent Developments/Updates
6.10 Ruipu Biotechnology
6.10.1 Ruipu Biotechnology Corporation Information
6.10.2 Ruipu Biotechnology Description and Business Overview
6.10.3 Ruipu Biotechnology Chicken Marek's Disease Live Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Ruipu Biotechnology Chicken Marek's Disease Live Vaccine Product Portfolio
6.10.5 Ruipu Biotechnology Recent Developments/Updates
6.11 Sinopharm Animal Health
6.11.1 Sinopharm Animal Health Corporation Information
6.11.2 Sinopharm Animal Health Chicken Marek's Disease Live Vaccine Description and Business Overview
6.11.3 Sinopharm Animal Health Chicken Marek's Disease Live Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Sinopharm Animal Health Chicken Marek's Disease Live Vaccine Product Portfolio
6.11.5 Sinopharm Animal Health Recent Developments/Updates
6.12 Harbin Pharmaceutical Group Biological Vaccine
6.12.1 Harbin Pharmaceutical Group Biological Vaccine Corporation Information
6.12.2 Harbin Pharmaceutical Group Biological Vaccine Chicken Marek's Disease Live Vaccine Description and Business Overview
6.12.3 Harbin Pharmaceutical Group Biological Vaccine Chicken Marek's Disease Live Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Harbin Pharmaceutical Group Biological Vaccine Chicken Marek's Disease Live Vaccine Product Portfolio
6.12.5 Harbin Pharmaceutical Group Biological Vaccine Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Chicken Marek's Disease Live Vaccine Industry Chain Analysis
7.2 Chicken Marek's Disease Live Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Chicken Marek's Disease Live Vaccine Production Mode & Process
7.4 Chicken Marek's Disease Live Vaccine Sales and Marketing
7.4.1 Chicken Marek's Disease Live Vaccine Sales Channels
7.4.2 Chicken Marek's Disease Live Vaccine Distributors
7.5 Chicken Marek's Disease Live Vaccine Customers
8 Chicken Marek's Disease Live Vaccine Market Dynamics
8.1 Chicken Marek's Disease Live Vaccine Industry Trends
8.2 Chicken Marek's Disease Live Vaccine Market Drivers
8.3 Chicken Marek's Disease Live Vaccine Market Challenges
8.4 Chicken Marek's Disease Live Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Chicken Marek's Disease Live Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Chicken Marek's Disease Live Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Chicken Marek's Disease Live Vaccine Market Competitive Situation by Manufacturers in 2023
Table 4. Global Chicken Marek's Disease Live Vaccine Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Chicken Marek's Disease Live Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Chicken Marek's Disease Live Vaccine Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Chicken Marek's Disease Live Vaccine Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Chicken Marek's Disease Live Vaccine Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Chicken Marek's Disease Live Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Chicken Marek's Disease Live Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Chicken Marek's Disease Live Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Chicken Marek's Disease Live Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Chicken Marek's Disease Live Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chicken Marek's Disease Live Vaccine as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Chicken Marek's Disease Live Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Chicken Marek's Disease Live Vaccine Sales by Region (2019-2024) & (K Units)
Table 18. Global Chicken Marek's Disease Live Vaccine Sales Market Share by Region (2019-2024)
Table 19. Global Chicken Marek's Disease Live Vaccine Sales by Region (2025-2030) & (K Units)
Table 20. Global Chicken Marek's Disease Live Vaccine Sales Market Share by Region (2025-2030)
Table 21. Global Chicken Marek's Disease Live Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Chicken Marek's Disease Live Vaccine Revenue Market Share by Region (2019-2024)
Table 23. Global Chicken Marek's Disease Live Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Chicken Marek's Disease Live Vaccine Revenue Market Share by Region (2025-2030)
Table 25. North America Chicken Marek's Disease Live Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Chicken Marek's Disease Live Vaccine Sales by Country (2019-2024) & (K Units)
Table 27. North America Chicken Marek's Disease Live Vaccine Sales by Country (2025-2030) & (K Units)
Table 28. North America Chicken Marek's Disease Live Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Chicken Marek's Disease Live Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Chicken Marek's Disease Live Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Chicken Marek's Disease Live Vaccine Sales by Country (2019-2024) & (K Units)
Table 32. Europe Chicken Marek's Disease Live Vaccine Sales by Country (2025-2030) & (K Units)
Table 33. Europe Chicken Marek's Disease Live Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Chicken Marek's Disease Live Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Chicken Marek's Disease Live Vaccine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Chicken Marek's Disease Live Vaccine Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Chicken Marek's Disease Live Vaccine Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Chicken Marek's Disease Live Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Chicken Marek's Disease Live Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Chicken Marek's Disease Live Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Chicken Marek's Disease Live Vaccine Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Chicken Marek's Disease Live Vaccine Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Chicken Marek's Disease Live Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Chicken Marek's Disease Live Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Chicken Marek's Disease Live Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Chicken Marek's Disease Live Vaccine Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Chicken Marek's Disease Live Vaccine Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Chicken Marek's Disease Live Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Chicken Marek's Disease Live Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Chicken Marek's Disease Live Vaccine Sales (K Units) by Type (2019-2024)
Table 51. Global Chicken Marek's Disease Live Vaccine Sales (K Units) by Type (2025-2030)
Table 52. Global Chicken Marek's Disease Live Vaccine Sales Market Share by Type (2019-2024)
Table 53. Global Chicken Marek's Disease Live Vaccine Sales Market Share by Type (2025-2030)
Table 54. Global Chicken Marek's Disease Live Vaccine Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Chicken Marek's Disease Live Vaccine Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Chicken Marek's Disease Live Vaccine Revenue Market Share by Type (2019-2024)
Table 57. Global Chicken Marek's Disease Live Vaccine Revenue Market Share by Type (2025-2030)
Table 58. Global Chicken Marek's Disease Live Vaccine Price (US$/Unit) by Type (2019-2024)
Table 59. Global Chicken Marek's Disease Live Vaccine Price (US$/Unit) by Type (2025-2030)
Table 60. Global Chicken Marek's Disease Live Vaccine Sales (K Units) by Application (2019-2024)
Table 61. Global Chicken Marek's Disease Live Vaccine Sales (K Units) by Application (2025-2030)
Table 62. Global Chicken Marek's Disease Live Vaccine Sales Market Share by Application (2019-2024)
Table 63. Global Chicken Marek's Disease Live Vaccine Sales Market Share by Application (2025-2030)
Table 64. Global Chicken Marek's Disease Live Vaccine Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Chicken Marek's Disease Live Vaccine Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Chicken Marek's Disease Live Vaccine Revenue Market Share by Application (2019-2024)
Table 67. Global Chicken Marek's Disease Live Vaccine Revenue Market Share by Application (2025-2030)
Table 68. Global Chicken Marek's Disease Live Vaccine Price (US$/Unit) by Application (2019-2024)
Table 69. Global Chicken Marek's Disease Live Vaccine Price (US$/Unit) by Application (2025-2030)
Table 70. Harbin Weike Biotechnology Corporation Information
Table 71. Harbin Weike Biotechnology Description and Business Overview
Table 72. Harbin Weike Biotechnology Chicken Marek's Disease Live Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Harbin Weike Biotechnology Chicken Marek's Disease Live Vaccine Product
Table 74. Harbin Weike Biotechnology Recent Developments/Updates
Table 75. Harbin Guosheng Biotechnology Corporation Information
Table 76. Harbin Guosheng Biotechnology Description and Business Overview
Table 77. Harbin Guosheng Biotechnology Chicken Marek's Disease Live Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Harbin Guosheng Biotechnology Chicken Marek's Disease Live Vaccine Product
Table 79. Harbin Guosheng Biotechnology Recent Developments/Updates
Table 80. Fujian Shengwei Biotechnology Corporation Information
Table 81. Fujian Shengwei Biotechnology Description and Business Overview
Table 82. Fujian Shengwei Biotechnology Chicken Marek's Disease Live Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Fujian Shengwei Biotechnology Chicken Marek's Disease Live Vaccine Product
Table 84. Fujian Shengwei Biotechnology Recent Developments/Updates
Table 85. Liaoning Yikang Biology Corporation Information
Table 86. Liaoning Yikang Biology Description and Business Overview
Table 87. Liaoning Yikang Biology Chicken Marek's Disease Live Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Liaoning Yikang Biology Chicken Marek's Disease Live Vaccine Product
Table 89. Liaoning Yikang Biology Recent Developments/Updates
Table 90. Boehringer Ingelheim Animal Health Corporation Information
Table 91. Boehringer Ingelheim Animal Health Description and Business Overview
Table 92. Boehringer Ingelheim Animal Health Chicken Marek's Disease Live Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Boehringer Ingelheim Animal Health Chicken Marek's Disease Live Vaccine Product
Table 94. Boehringer Ingelheim Animal Health Recent Developments/Updates
Table 95. MSD Animal Health Corporation Information
Table 96. MSD Animal Health Description and Business Overview
Table 97. MSD Animal Health Chicken Marek's Disease Live Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. MSD Animal Health Chicken Marek's Disease Live Vaccine Product
Table 99. MSD Animal Health Recent Developments/Updates
Table 100. Ceva Corporation Information
Table 101. Ceva Description and Business Overview
Table 102. Ceva Chicken Marek's Disease Live Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Ceva Chicken Marek's Disease Live Vaccine Product
Table 104. Ceva Recent Developments/Updates
Table 105. Zoetis Corporation Information
Table 106. Zoetis Description and Business Overview
Table 107. Zoetis Chicken Marek's Disease Live Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Zoetis Chicken Marek's Disease Live Vaccine Product
Table 109. Zoetis Recent Developments/Updates
Table 110. Dahuanong Corporation Information
Table 111. Dahuanong Description and Business Overview
Table 112. Dahuanong Chicken Marek's Disease Live Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Dahuanong Chicken Marek's Disease Live Vaccine Product
Table 114. Dahuanong Recent Developments/Updates
Table 115. Ruipu Biotechnology Corporation Information
Table 116. Ruipu Biotechnology Description and Business Overview
Table 117. Ruipu Biotechnology Chicken Marek's Disease Live Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Ruipu Biotechnology Chicken Marek's Disease Live Vaccine Product
Table 119. Ruipu Biotechnology Recent Developments/Updates
Table 120. Sinopharm Animal Health Corporation Information
Table 121. Sinopharm Animal Health Description and Business Overview
Table 122. Sinopharm Animal Health Chicken Marek's Disease Live Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Sinopharm Animal Health Chicken Marek's Disease Live Vaccine Product
Table 124. Sinopharm Animal Health Recent Developments/Updates
Table 125. Harbin Pharmaceutical Group Biological Vaccine Corporation Information
Table 126. Harbin Pharmaceutical Group Biological Vaccine Description and Business Overview
Table 127. Harbin Pharmaceutical Group Biological Vaccine Chicken Marek's Disease Live Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Harbin Pharmaceutical Group Biological Vaccine Chicken Marek's Disease Live Vaccine Product
Table 129. Harbin Pharmaceutical Group Biological Vaccine Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Chicken Marek's Disease Live Vaccine Distributors List
Table 133. Chicken Marek's Disease Live Vaccine Customers List
Table 134. Chicken Marek's Disease Live Vaccine Market Trends
Table 135. Chicken Marek's Disease Live Vaccine Market Drivers
Table 136. Chicken Marek's Disease Live Vaccine Market Challenges
Table 137. Chicken Marek's Disease Live Vaccine Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Chicken Marek's Disease Live Vaccine
Figure 2. Global Chicken Marek's Disease Live Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Chicken Marek's Disease Live Vaccine Market Share by Type in 2023 & 2030
Figure 4. Chicken Marek's Disease Live Vaccine Product Picture
Figure 5. Chicken Marek's Disease Bivalent Live Vaccine Product Picture
Figure 6. Global Chicken Marek's Disease Live Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Chicken Marek's Disease Live Vaccine Market Share by Application in 2023 & 2030
Figure 8. Government Tender
Figure 9. Marketing
Figure 10. Global Chicken Marek's Disease Live Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global Chicken Marek's Disease Live Vaccine Market Size (2019-2030) & (US$ Million)
Figure 12. Global Chicken Marek's Disease Live Vaccine Sales (2019-2030) & (K Units)
Figure 13. Global Chicken Marek's Disease Live Vaccine Average Price (US$/Unit) & (2019-2030)
Figure 14. Chicken Marek's Disease Live Vaccine Report Years Considered
Figure 15. Chicken Marek's Disease Live Vaccine Sales Share by Manufacturers in 2023
Figure 16. Global Chicken Marek's Disease Live Vaccine Revenue Share by Manufacturers in 2023
Figure 17. The Global 5 and 10 Largest Chicken Marek's Disease Live Vaccine Players: Market Share by Revenue in 2023
Figure 18. Chicken Marek's Disease Live Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 19. Global Chicken Marek's Disease Live Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 20. North America Chicken Marek's Disease Live Vaccine Sales Market Share by Country (2019-2030)
Figure 21. North America Chicken Marek's Disease Live Vaccine Revenue Market Share by Country (2019-2030)
Figure 22. United States Chicken Marek's Disease Live Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 23. Canada Chicken Marek's Disease Live Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Europe Chicken Marek's Disease Live Vaccine Sales Market Share by Country (2019-2030)
Figure 25. Europe Chicken Marek's Disease Live Vaccine Revenue Market Share by Country (2019-2030)
Figure 26. Germany Chicken Marek's Disease Live Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. France Chicken Marek's Disease Live Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. U.K. Chicken Marek's Disease Live Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Italy Chicken Marek's Disease Live Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Netherlands Chicken Marek's Disease Live Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Chicken Marek's Disease Live Vaccine Sales Market Share by Region (2019-2030)
Figure 32. Asia Pacific Chicken Marek's Disease Live Vaccine Revenue Market Share by Region (2019-2030)
Figure 33. China Chicken Marek's Disease Live Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Japan Chicken Marek's Disease Live Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. South Korea Chicken Marek's Disease Live Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. India Chicken Marek's Disease Live Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Chicken Marek's Disease Live Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. China Taiwan Chicken Marek's Disease Live Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Chicken Marek's Disease Live Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Latin America Chicken Marek's Disease Live Vaccine Sales Market Share by Country (2019-2030)
Figure 41. Latin America Chicken Marek's Disease Live Vaccine Revenue Market Share by Country (2019-2030)
Figure 42. Mexico Chicken Marek's Disease Live Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Brazil Chicken Marek's Disease Live Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Argentina Chicken Marek's Disease Live Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Colombia Chicken Marek's Disease Live Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Chicken Marek's Disease Live Vaccine Sales Market Share by Country (2019-2030)
Figure 47. Middle East & Africa Chicken Marek's Disease Live Vaccine Revenue Market Share by Country (2019-2030)
Figure 48. Turkey Chicken Marek's Disease Live Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Saudi Arabia Chicken Marek's Disease Live Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. UAE Chicken Marek's Disease Live Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Global Sales Market Share of Chicken Marek's Disease Live Vaccine by Type (2019-2030)
Figure 52. Global Revenue Market Share of Chicken Marek's Disease Live Vaccine by Type (2019-2030)
Figure 53. Global Chicken Marek's Disease Live Vaccine Price (US$/Unit) by Type (2019-2030)
Figure 54. Global Sales Market Share of Chicken Marek's Disease Live Vaccine by Application (2019-2030)
Figure 55. Global Revenue Market Share of Chicken Marek's Disease Live Vaccine by Application (2019-2030)
Figure 56. Global Chicken Marek's Disease Live Vaccine Price (US$/Unit) by Application (2019-2030)
Figure 57. Chicken Marek's Disease Live Vaccine Value Chain
Figure 58. Chicken Marek's Disease Live Vaccine Production Process
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Distributors Profiles
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
